SCHEMBL4438531

SCHEMBL4438531

CC(C)(C)OC(=O)C1CC(c2cnc(C(=O)O)cn2)=CCN1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4441491 0.89 RECQL (0.33) GPR119
SCHEMBL4427892 0.73 CRBN (0.34) GPR119
SCHEMBL8313985 0.71 NPC1 (0.36)
SCHEMBL2467200 0.71
SCHEMBL7527330 0.68 MAPT (0.41)
SCHEMBL8137468 0.68 MAPK1 (0.33)
SCHEMBL7261773 0.68 CYP11B1 (0.38) GPR119
SCHEMBL31701242 0.67 GRM1 (0.55) GPR119
SCHEMBL64945 0.67 GRM1 (0.55) GPR119
SCHEMBL7014119 0.67 MAPK1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125748-A2 ACYLAMINOPYRAZOLES AS FGFR INHIBITORS AstraZeneca AB (SE) 2009-12-02 EP disclosed
WO-2008075068-A2 ACYLAMINOPYRAZOLES AS FGFR INHIBITORS ASTRAZENECA AB (SE) 2008-06-26 WO disclosed